Atrial Fibrillation, Stroke, and Bleeding in Patients Undergoing Aortic Biovalve Implantation (CAREAVR)

University of Turku

Status: Completed

Conditions: Atrial Fibrillation; Stroke; Transient Ischemic Attack; Aortic Stenosis; Bleeding

Study type: Observational

Funder types: Other

Identifiers

NCT02626871

T39/2015

Details and patient eligibility

About

The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.

Enrollment: 850 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients undergoing aortic valve bioprosthesis implantation

Exclusion criteria

• mechanical heart valves in any position